logo

Amarin Corp Plc (AMRN)



Trade AMRN now with
  Date
  Headline
5/29/2019 6:19:58 AM Amarin: FDA Grants Priority Review For Vascepa SNDA Seeking Cardiovascular Risk Reduction Indication
2/27/2019 5:06:15 AM Amarin Q4 GAAP Loss Per Share $0.11; Non-GAAP Loss Per Share $0.09
11/26/2018 9:00:24 PM Amarin Announces Pricing Of Underwritten Public Offering Of ADSs For Gross Proceeds Of About $200.0 Mln
11/1/2018 5:11:11 AM Amarin Corp Q3 GAAP Net Loss $24.5 Mln Or $0.08/Shr Vs Loss $10.8 Mln Or $0.04/shr Last Year
9/24/2018 4:53:02 AM Amarin Says REDUCE-IT Study Met Its Primary Endpoint
8/26/2018 11:06:31 AM Amarin Says REDUCE-IT Study Remains On-Track For Report Of Top-Line Results Before End Of September 2018
8/1/2018 5:03:44 AM Amarin Corp Q2 Loss Per Share $0.12 Vs Loss $0.05 Last Year
7/26/2018 8:51:35 AM Amarin Reports Approval For Vascepa In UAE
5/24/2018 4:35:38 PM Amarin Announces Patent Litigation Settlement Agreement With Teva
5/2/2018 5:04:33 AM Amarin Corp Q1 Net Loss $24.1 Mln Or $0.08/Shr Vs Loss $20.9 Mln Or $0.08/Shr Last Year